Program Description
Chemotherapy can
impose a substantial burden on patients with cancer who experience acute and
chronic chemotherapy-related adverse events (AEs), including nausea, vomiting,
fatigue, and pain. These AEs may occur soon after treatment initiation, leading
to dose reductions and treatment delays. Gastrointestinal toxicities remain
among the most common chemotherapy-related complications, as nearly one‑third
of patients receive highly or moderately emetogenic regimens with rapid-onset
nausea and vomiting, and many more experience these symptoms at some point
during treatment; these AEs can often persist beyond active treatment, further
impairing quality of life. Addressing these AEs may pose particular challenges
in patients with cancer who are frail, older, or with polypharmacy for whom
standard analgesics, antiemetics, and adjuvant pain therapies may be less
tolerated or carry additive risks. It is important for pharmacists and pharmacy
technicians to be aware of over-the-counter integrative oncology and homeopathic
products since patients and caregivers may actively seek these options for
symptom relief as part of supportive cancer care and self-management. This
article is designed to equip pharmacists in oncology and community settings
with the clinical knowledge, communication skills, and practical strategies
needed to evaluate chemotherapy-related symptom burden, discuss integrative
options such as homeopathy in an evidence-informed manner, and optimize
patient-centered supportive care. Pharmacists and pharmacy technicians will
examine chemotherapy-related AEs and integrative options to support patients
and caregivers in shared decision-making regarding symptom management with
realistic expectations on the safe use of homeopathic therapies.
Target
audience: Community and Oncology pharmacists
Type of activity: Application
Release date: April 28,2026
Expiration date: April 28, 2028
Learner level: Foundational, Intermediate, Advanced
Time to complete activity: 2.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain the clinical evidence, regulatory status, and appropriate indications for homeopathic medications in managing common chemotherapy-related adverse events
- Investigate the clinical trial data and safety profiles of homeopathic medications to incorporate evidence-based homeopathic options into oncology treatment plans using suitable risk-benefit frameworks
- Demonstrate patient-centered communication to assess patient preferences for homeopathic therapies and counsel on their benefits for symptom management versus traditional treatments